Two nomograms for determining extended-dosing intervals for gentamicin in neonates

American Journal of Health-System Pharmacy

Volumn 65, Issue 7, 2008, Pages 624-630

  Murphy, John E ^a   Roether, Anthony M ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b United Drugs   (United States)

Author keywords

Aminoglycosides; Blood levels; Dosage; Drugs, body distribution; Gentamicin; Half life; Injections; Methodology; Nomograms; Pediatrics; Pharmacokinetics

Indexed keywords

GENTAMICIN;

ACCURACY; ARTICLE; CONCENTRATION RESPONSE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INFUSION; DRUG RELEASE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VALIDATION STUDY;

EID: 41749122619     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070314     Document Type: Article

References (22)

1. Young TE, Mangum OB. Neofax. 19th ed. Raleigh, NC: Acorn; 2006:31-2.
2. De Hoog M, Mouton JW, Schoemaker RC et al. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. Clin Pharmacol Ther. 2002; 71:349-58.
3. Stolk LM, Degraeuwe PL, Nieman FH et al. Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit. 2002; 24:527-31.
4. Hansen A, Forbes P, Arnold A et al. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol. 2003; 23:635-9.
5. Rastogi A, Agarwal G, Pyati S et al. Comparison of two gentamicin dosing schedules in very low birth weight infants. Pediatr Infect Dis J. 2002; 21:234-40.
6. DiCenzo R, Forrest A, Slish JC et al. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy. 2003; 23:585-91.
7. De Hoog M, Schoemaker RC, Mouton JW et al. Tobramycin population pharmacokinetics in neonates. Clin Pharmacol Ther. 1997; 62:392-9.
8. De Hoog MD, Mouton JW, van den Anker JN. Thoughts on "population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates." Ther Drug Monit. 2003; 25:256-7. Letter.
9. Rybak MJ, Abate BJ, Kang SL et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother. 1999; 43:1549-55.
10. Murphy JE. Prediction of gentamicin peak and trough concentrations from six extended-interval dosing protocols for neonates. Am J Health-Syst Pharm. 2005; 62:823-7.
11. Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. National Institutes of Health, National Institute for Child Health and Human Development. Most recent update Nov 16, 2005. www.nichd.nih.gov/cochrane (accessed 2007 Jun 2).
12. Langlass TM, Mickle TR. Standard gentamicin dosage regimen in neonates. Am J Health-Syst Pharm. 1999; 56:440-3.
13. Zhanel GG, Hoban DJ, Harding GK. The postantibiotic effect: a review of in vitro and in vivo data. DICP. 1991; 25:153-63.
14. Best EJ, Palasanthiran P, Gazarian M. Extended-interval aminoglycosides in children: more guidance is needed. Pediatrics. 2005; 115:827-8. Letter.
15. Murphy JE, Austin ML, Frye RF. Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. Am J Health-Syst Pharm. 1998; 55:2280-8.
16. Murphy JE, Carter JT. Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines. Hosp Pharm. 1996; 31:1283-9.
17. Patel R, Murphy JE. Use of pooled data to compare published and hospital-generated gentamicin dosing protocols for neonates. Presented at ASHP Midyear Clinical Meeting, Atlanta, GA; 2002 Dec 11.
18. Murphy JE. Aminoglycosides. In: Murphy JE, ed. Clinical pharmacokinetics, 3rd ed. Bethesda, MD: American Society of Health-System Pharmacists; 2005:12.
19. Smith RV, Stewart JT. Textbook of biopharmaceutic analysis. Philadelphia: Lea and Febiger; 1981:85.
20. Lacy MK, Nicolau DP, Nightingale CH et al. The pharmacodynamics of aminoglycosides. Clin Infect Dis. 1998; 27:23-7.
21. Boyle EM, Brookes I, Nye K et al. "Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens. BMC Pediatrics. 2006; 6:1-7.
22. Knight JA, Davis EM, Manouilov K et al. The effect of postnatal age on gentamicin pharmacokinetics in neonates. Pharmacotherapy. 2003; 23:992-6.